Change ahead for Hospira as CEO and COO announce retirements
This article was originally published in Clinica
Executive Summary
The search has begun for a new CEO at specialty pharmaceutical and medication delivery firm Hospira, after Christopher Begley announced his retirement from the position after six years in the role.